SEC 13F Intelligence

First American Bank / EW

First American Bank’s Edwards Lifesciences Corp Position

Does First American Bank own Edwards Lifesciences Corp (EW)? Yes149.4K shares worth $12M (+0.75% of its 13F portfolio) as of Q1 2026, up from 149.2K shares the prior filed quarter.

Position Value
$12M
Q1 2026
Shares
149.4K
% of Portfolio
+0.75%
Quarters Held
20
currently held

Position History EW

Reported value by quarter
Q4 ’18: $9MQ4 ’18Q1 ’19: $11MQ2 ’19: $10MQ4 ’19: $13MQ4 ’19Q1 ’20: $10MQ2 ’20: $11MQ3 ’20: $13MQ3 ’20Q4 ’20: $14MQ1 ’21: $13MQ2 ’21: $16MQ2 ’21Q3 ’21: $17MQ4 ’21: $20MQ2 ’24: $18MQ2 ’24Q3 ’24: $9MQ4 ’24: $10MQ1 ’25: $10MQ1 ’25Q2 ’25: $11MQ3 ’25: $11MQ4 ’25: $13MQ4 ’25Q1 ’26: $12Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026149.4K$12M+0.75%
Q4 2025149.2K$13M+0.77%
Q3 2025143.2K$11M+0.70%
Q2 2025142.6K$11M+0.76%
Q1 2025143.2K$10M+0.77%
Q4 2024141.3K$10M+0.74%
Q3 2024142.3K$9M+0.67%
Q2 2024151.3K$18M+1.51%
Q4 2021151.3K$20M+1.04%
Q3 2021151.2K$17M+0.99%
Q2 2021151.8K$16M+0.91%
Q1 2021152.5K$13M+0.80%
Q4 2020152.0K$14M+0.93%
Q3 2020160.8K$13M+0.76%
Q2 2020161.0K$11M+0.70%
Q1 202054.1K$10M+0.76%
Q4 201954.4K$13M+0.79%
Q2 201955.0K$10M+0.70%
Q1 201956.0K$11M+0.77%
Q4 201857.1K$9M+0.68%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See First American Bank’s full portfolio or all institutional holders of EW.